Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective
Genes · 2025
DOI: 10.3390/genes16010098 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Genes, 2025. Verfasst von Hanxiang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou 221004, China. Hauptthemen laut MEDLINE: Coronary Artery Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Coronary atherosclerosis (CAD) is characterized by arterial intima lipid deposition, chronic inflammation, and fibrous tissue proliferation, leading to arterial wall thickening and lumen narrowing. As the primary cause of coronary heart disease and acute coronary syndrome, CAD significantly impacts global health. Recent genetic studies have demonstrated CAD’s polygenic and multifactorial nature, providing molecular insights for early diagnosis and risk assessment. This review analyzes recent advances in CAD-related genetic markers and evaluates their diagnostic potential, focusing on their applications in diagnosis and risk stratification within precision medicine.
Methods
We conducted a systematic review of CAD genomic studies from PubMed and Web of Science databases, analyzing findings from genome-wide association studies (GWASs), gene sequencing, transcriptomics, and epigenomics research.
Results
GWASs and sequencing studies have identified key genetic variations associated with CAD, including JCAD/KIAA1462, GUCY1A3, PCSK9, and SORT1, which regulate inflammation, lipid metabolism, and vascular function. Transcriptomic and epigenomic analyses have revealed disease-specific gene expression patterns, DNA methylation signatures, and regulatory non-coding RNAs (miRNAs and lncRNAs), providing new approaches for early detection.
Conclusions
While genetic marker research in CAD has advanced significantly, clinical implementation faces challenges including marker dynamics, a lack of standardization, and integration with conventional diagnostics. Future research should prioritize developing standardized guidelines, conducting large-scale prospective studies, and enhancing multi-omics data integration to advance genomic diagnostics in CAD, ultimately improving patient outcomes through precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Imaging, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou 221004, China.
- Medical and Information College, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou 221004, China.
- Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15260, USA.
- Greenwich Hospital, Yale New Haven Health, Greenwich, CT 06519, USA.
- Department of Internal Medicine, Montefiore Medical Center Wakefield Campus, 600 East 233rd Street, Bronx, NY 10466, USA.
- Department of Radiology, Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Yixin Yang
Zitieren
APA
Liu, H., Zhang, Y., Zhao, Y., Li, Y., Zhang, X., Bao, L., Yan, R., Yang, Y., Zhou, H., Zhang, J., & Song, S. (2025). Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective. Genes. https://doi.org/10.3390/genes16010098
Vancouver
Liu H, Zhang Y, Zhao Y, Li Y, Zhang X, Bao L, et al. Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective. Genes. 2025. doi:10.3390/genes16010098
BibTeX
@article{Liu2025,
author = {Liu, Hanxiang and Zhang, Yuchen and Zhao, Yueyan and Li, Yuzhen and Zhang, Xiaofeng and Bao, Lingyu and Yan, Rongkai and Yang, Yixin and Zhou, Huixian and Zhang, Jinming and Song, Siyuan},
title = {Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16010098}
}
EUVIMED